Sphingosylphosphorylcholine-induced contraction of feline ileal smooth muscle cells is mediated by Gαi3 protein and MAPK
Introduction
A variety of phosphorylated lipids act as intracellular and extracellular messengers for a diverse array of cellular processes, and numerous studies have provided abundant evidence of their importance in metabolic events [1], [2], [3], [4], [5]. Sphingolipids display a wide spectrum of biological activities, including such effects as protection of cells from apoptosis [6], activation of calcium signalling [7] and stimulation of nitric oxide production [8]. Additional effects include modulation of phosphatidylserine homeostasis [9], cell proliferation [10], wound healing [11] and prevention of nerve excitation and neuronal degeneration [12]. An untimely or improper accumulation of sphingolipids results in pathological changes in brain and other organs [13]. One of the sphingolipids, sphingosylphosphorylcholine (SPC), is generated by N-deacylation of sphingomyelin, which is one of the most abundant lipids in the cell membrane. SPC has been shown to act as an extracellular signal. For example, in common with peptide growth factors, SPC rapidly activates mitogen-activated protein kinase (MAPK) and stimulates DNA synthesis in Swiss 3T3 fibroblasts [1], [14], [15].
It is presumed that SPC interacts with a seven-transmembrane-spanning domain G protein-coupled receptor (GPCR), because all SPC-stimulated signalling events are inhibited by pertussis toxin (PTX) treatment, demonstrating the involvement of a G protein that leads to stimulation of phospholipases A2 and C (PLA2 and PLC) [15], [16], [17].
Activation of MAPK leads to the phosphorylation of various proteins that regulate gene transcription factor phosphorylation and has been implicated in the stimulation of cell proliferation [18], [19]. MAPK is activated by a variety of extracellular stimuli, including peptide growth-promoting factors acting on tyrosine kinase receptors and heterotrimeric G protein-coupled receptor agonists. Although the activation of the MAPK pathway by receptors with tyrosine kinase activity is well defined, the signalling mechanism leading to MAPK activation via G protein-coupled receptors is less clear. Several G protein-coupled receptors, including lysophosphatidic acid (LPA) [20], M1 and M3 muscarinic ACh [21], ANG II [22], α2A-adrenergic [23], D2 dopamine [24] and bradykinin (BK) [25] receptors, have been shown to mediate the signalling pathway to activate MAPK. The signalling mechanism used by a given G protein-coupled receptor agonist to stimulate MAPK depends on the class of G protein and second messenger in a given cell type.
The best-characterized members of the MAPK superfamily of protein kinases are the extracellular signal-regulated protein kinases (Erk/MAPK or Erks, p42 and p44 kDa) [26]. The Erk/MAPK can be activated by many different stimuli and are involved in smooth muscle cell contraction. These proteins are activated when phosphorylated on both tyrosine and threonine residues. Activation of the MAPK pathway ultimately results in the phosphorylation of target enzyme essential for cellular responses. The protein directly responsible for Erk/MAPK phosphorylation is MAPK kinase (MEK)/Erk kinase [27].
It is also reported that SPC might be able to decrease the length of smooth muscle cells isolated from the rectosigmoid of the rabbit and pig vascular smooth muscle via the activation of MAPK [28] and Ca2+ signalling [8], respectively. In this study, we examined whether SPC-induced ileal smooth muscle cell contraction is G protein subtype specific and whether MAPK is related to the contraction and finally what are the components of the linkage of G protein and MAPK.
Section snippets
Preparation of ileal smooth muscle tissue squares
Adult male cats weighing between 2.5 and 4 kg were used in these experiments. After an overnight fast, they were anaesthetized with 10 mg/kg ketamine, and the maintenance doses of ketamine (2.5–5 mg/kg) were administered as needed. The abdomen was opened with a midline incision. Three-centimeter ileal segments were slipped over a glass rod and the longitudinal muscle layer was separated from the circular muscle layer by tangential stroking of the mesenteric attachment. The ileal segments were
PTX inhibits SPC-induced contraction in cat ileal smooth muscle cells
Fig. 1 shows the inhibition of SPC-induced contraction by PTX (upper panel) and G proteins expression (lower panel) in cat ileal smooth muscle cells. As in previous studies showing that SPC can contract gastrointestinal smooth muscle cells [28], SPC treatment (10−5 M) to isolated cat ileal smooth muscle cells caused 20.1% contraction, which was obtained in 1 min. Pretreatment of PTX (400 ng/ml) for 1 h reduced SPC-induced contraction significantly by 72.1%. With this result, it is supposed that
Discussion
In the present study, we have examined the effect of SPC on the contraction of cat ileal smooth muscle cells. SPC is a metabolite of sphingomyelin and produced by the enzymatic activity of sphingomyelin acylase, which is highly expressed in the stratum corneum from patients with atopic dermatitis [34]. In Pseudomonas sp. TK4, the enzymatic activity was found, which is called sphingolipids ceramide N-deacylase. In contrast, these pathways that produce SPC are poorly defined in mammalian cells.
References (48)
- et al.
Biochem. Biophys. Res. Commun.
(1991) - et al.
Kidney Int.
(1998) - et al.
FEBS Lett.
(1999) - et al.
J. Invest. Dermatol. Symp. Proc.
(1999) - et al.
J. Invest. Dermatol.
(1996) - et al.
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(1999) - et al.
J. Biol. Chem.
(1995) - et al.
J. Biol. Chem.
(1995) - et al.
Trends Biochem. Sci.
(1997) - et al.
J. Biol. Chem.
(1993)